S&P 500 · Health Care · USD · FY end 2025-12-31
West Pharmaceutical Services (WST) financials — revenue, earnings, margins, balance sheet, cash flow and dividends. 10-year history sourced from SEC filings.
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| FY2025 | 3.07B | 493.70M | 6.79 | 468.90M |
| FY2024 | 2.89B | 492.70M | 6.69 | 276.40M |
| FY2023 | 2.95B | 593.40M | 7.88 | 414.50M |
| FY2022 | 2.89B | 585.90M | 7.73 | 439.40M |
| FY2021 | 2.83B | 661.80M | 8.67 | 330.60M |